Both multiplex platforms can test the two most mutated genes in NSCLC ADC, which are EGFR and KRAS. In our cohort results aligned with real life, with KRAS (n = 9, 21%) and EGFR (n = 8, 19%) being the driver alterations most commonly detected. This evidence concerns the gene EGFR and non-small cell lung carcinoma.